(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

IDACIO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

IDACIO

ST13

US500000097373891

Class

5

Filing

97373891

Registration

7177855

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

22

Latest update

09/26/2023

Trademark type

Word

Nice classes

5

Filing date

04/21/2022

Registration date

09/26/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/26/2023

Last transaction

09/26/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

07/01/2023

First use in commerce

07/01/2023

Drawing code

4

Owner type

16

Owner location

Bad Homburg, DE

Examiner

STURMAN, JOSHUA

Law office

L30

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Fresenius Kabi Deutschland GmbH

Representatives

Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for human use for the treatment of neurological diseases and disordersimmunological diseases and disordersinflammatory diseases and disordersoncological diseases and disorders and viral infections; Pharmaceutical preparationsimmunosuppressants; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of plaque psoriasispsoriatic arthritisrheumatoid arthritisaxial spondyloarthritispolyarticular juvenile idiopathic arthritis and active enthesitis related arthritisCrohn's diseaseulcerative colitishidradenitis colitishidradenitis suppurativa and non-infectious uveitis; Diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; Biologicsbiological preparations for the treatment of neurological diseases and disordersimmunological diseases and disordersinflammatory diseases and disordersoncological diseases and disorders and viral infections; Biologicsbiological preparations for the treatment of ankylosing spondylitis; Biological preparations for the treatment of and reducing signs and symptoms in adult patients with active ankylosing spondylitis; Protein therapeuticsprotein supplements; Pharmaceutical preparations for treating ankylosing spondylitis; Pharmaceutical preparations for the treatment of and for reducing signs and symptoms in adult patients with active ankylosing spondylitis; Pharmaceutical preparations for treating a wide variety of autoimmune diseasesillnesses and conditions

Publications

History of USPTO decisions and trademark events.

22 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

09/26/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

09/26/2023

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/22/2023

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/21/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/02/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/02/2023

IUAF

USE AMENDMENT FILED

07/14/2023

EISU

TEAS STATEMENT OF USE RECEIVED

07/14/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

01/17/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/22/2022

PUBO

PUBLISHED FOR OPPOSITION

11/22/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/02/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/13/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/07/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/07/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/07/2022

GPRN

NOTIFICATION OF PRIORITY ACTION E-MAILED

07/12/2022

GPRA

PRIORITY ACTION E-MAILED

07/12/2022

CPRA

PRIORITY ACTION WRITTEN

07/12/2022

DOCK

ASSIGNED TO EXAMINER

07/05/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/27/2022

NWAP

NEW APPLICATION ENTERED

04/25/2022

Continuous trademark protection

Get notified about every new filing that threatens IDACIO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.